India
· Delayed Price · Currency is INR AstraZeneca Pharma India Statistics
Total Valuation
BOM:506820 has a market cap or net worth of INR 222.41 billion. The enterprise value is 217.40 billion.
| Market Cap | 222.41B |
| Enterprise Value | 217.40B |
Important Dates
The next estimated earnings date is Friday, August 8, 2025.
| Earnings Date | Aug 8, 2025 |
| Ex-Dividend Date | Jul 5, 2024 |
Share Statistics
BOM:506820 has 25.00 million shares outstanding. The number of shares has decreased by -0.01% in one year.
| Current Share Class | 25.00M |
| Shares Outstanding | 25.00M |
| Shares Change (YoY) | -0.01% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 8.02% |
| Owned by Institutions (%) | 7.33% |
| Float | 4.14M |
Valuation Ratios
The trailing PE ratio is 192.14.
| PE Ratio | 192.14 |
| Forward PE | n/a |
| PS Ratio | 12.96 |
| PB Ratio | 28.87 |
| P/TBV Ratio | 28.90 |
| P/FCF Ratio | 349.64 |
| P/OCF Ratio | 340.28 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 85.60, with an EV/FCF ratio of 341.77.
| EV / Earnings | 187.83 |
| EV / Sales | 12.67 |
| EV / EBITDA | 85.60 |
| EV / EBIT | 101.60 |
| EV / FCF | 341.77 |
Financial Position
The company has a current ratio of 1.91, with a Debt / Equity ratio of 0.05.
| Current Ratio | 1.91 |
| Quick Ratio | 1.03 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.14 |
| Debt / FCF | 0.56 |
| Interest Coverage | 146.56 |
Financial Efficiency
Return on equity (ROE) is 15.62% and return on invested capital (ROIC) is 17.57%.
| Return on Equity (ROE) | 15.62% |
| Return on Assets (ROA) | 10.30% |
| Return on Invested Capital (ROIC) | 17.57% |
| Return on Capital Employed (ROCE) | 26.25% |
| Revenue Per Employee | 28.60M |
| Profits Per Employee | 1.93M |
| Employee Count | 600 |
| Asset Turnover | 1.32 |
| Inventory Turnover | 2.48 |
Taxes
In the past 12 months, BOM:506820 has paid 406.20 million in taxes.
| Income Tax | 406.20M |
| Effective Tax Rate | 25.98% |
Stock Price Statistics
The stock price has increased by +37.54% in the last 52 weeks. The beta is 0.03, so BOM:506820's price volatility has been lower than the market average.
| Beta (5Y) | 0.03 |
| 52-Week Price Change | +37.54% |
| 50-Day Moving Average | 8,694.94 |
| 200-Day Moving Average | 7,557.78 |
| Relative Strength Index (RSI) | 59.66 |
| Average Volume (20 Days) | 7,766 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:506820 had revenue of INR 17.16 billion and earned 1.16 billion in profits. Earnings per share was 46.30.
| Revenue | 17.16B |
| Gross Profit | 7.53B |
| Operating Income | 2.14B |
| Pretax Income | 1.56B |
| Net Income | 1.16B |
| EBITDA | 2.54B |
| EBIT | 2.14B |
| Earnings Per Share (EPS) | 46.30 |
Balance Sheet
The company has 5.37 billion in cash and 357.30 million in debt, giving a net cash position of 5.01 billion or 200.39 per share.
| Cash & Cash Equivalents | 5.37B |
| Total Debt | 357.30M |
| Net Cash | 5.01B |
| Net Cash Per Share | 200.39 |
| Equity (Book Value) | 7.70B |
| Book Value Per Share | 308.14 |
| Working Capital | 6.39B |
Cash Flow
In the last 12 months, operating cash flow was 653.60 million and capital expenditures -17.50 million, giving a free cash flow of 636.10 million.
| Operating Cash Flow | 653.60M |
| Capital Expenditures | -17.50M |
| Free Cash Flow | 636.10M |
| FCF Per Share | 25.44 |
Margins
Gross margin is 43.89%, with operating and profit margins of 12.47% and 6.74%.
| Gross Margin | 43.89% |
| Operating Margin | 12.47% |
| Pretax Margin | 9.11% |
| Profit Margin | 6.74% |
| EBITDA Margin | 14.80% |
| EBIT Margin | 12.47% |
| FCF Margin | 3.71% |
Dividends & Yields
This stock pays an annual dividend of 32.00, which amounts to a dividend yield of 0.36%.
| Dividend Per Share | 32.00 |
| Dividend Yield | 0.36% |
| Dividend Growth (YoY) | 50.00% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 51.84% |
| Buyback Yield | 0.01% |
| Shareholder Yield | 0.33% |
| Earnings Yield | 0.52% |
| FCF Yield | 0.29% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 15, 2006. It was a forward split with a ratio of 5.
| Last Split Date | Jun 15, 2006 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |